Evidence map›Paper›PMID 42352076›Full record

ArticleAntioxidants (Basel, Switzerland)2026

Structural Characterization of a Novel Galactoarabinan from

Zanwen Zuo, Chen Yang, Wenli Liang, Qian Zhang, Yuliang Wang, Xiao Sheng, Qizhang Li

Abstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Zanwen ZuoInnovative Drug R & D Center, Anhui Provincial Engineering Laboratory for Efficient Utilization of Featured Resource Plants, Huaibei Key Laboratory of Efficient Cultivation and Utilization of Resource Plants, College of Life Sciences, Huaibei Normal University, Huaibei 235000, China.
Chen YangInnovative Drug R & D Center, Anhui Provincial Engineering Laboratory for Efficient Utilization of Featured Resource Plants, Huaibei Key Laboratory of Efficient Cultivation and Utilization of Resource Plants, College of Life Sciences, Huaibei Normal University, Huaibei 235000, China.
Wenli LiangInnovative Drug R & D Center, Anhui Provincial Engineering Laboratory for Efficient Utilization of Featured Resource Plants, Huaibei Key Laboratory of Efficient Cultivation and Utilization of Resource Plants, College of Life Sciences, Huaibei Normal University, Huaibei 235000, China.
Qian ZhangInnovative Drug R & D Center, Anhui Provincial Engineering Laboratory for Efficient Utilization of Featured Resource Plants, Huaibei Key Laboratory of Efficient Cultivation and Utilization of Resource Plants, College of Life Sciences, Huaibei Normal University, Huaibei 235000, China.
Yuliang WangSchool of Agriculture and Biology, Plant Biotechnology Research Center, Fudan-SJTU-Nottingham Plant Biotechnology R&D Center, Shanghai Jiao Tong University, Shanghai 200240, China.ORCID 0000-0001-6174-6365
Xiao ShengDepartment of Pharmaceutical Botany, School of Pharmacy, Naval Medical University, Shanghai 200433, China.
Qizhang LiInnovative Drug R & D Center, Anhui Provincial Engineering Laboratory for Efficient Utilization of Featured Resource Plants, Huaibei Key Laboratory of Efficient Cultivation and Utilization of Resource Plants, College of Life Sciences, Huaibei Normal University, Huaibei 235000, China.ORCID 0000-0001-7737-7787

Funding

College Students' Innovative Entrepreneurial Training Plan Program of Anhui Province S202510373065Natural Science Research Project of Anhui Educational Committee 2024AH051675Naval Medical University Campus Project 2023QN025Open Fund of Anhui Provincial Engineering Laboratory for Efficient Utilization of Featured Re-source Plants FRPOF202501Special Project of Science and Technology Cooperation and Exchange of Shanxi Province 202404041101028
6 · The paper itself

Abstract

The roots of

Indexed as

Baphicacanthus cusiagalactoarabinanimmunomodulationNan-Ban-Lan-GenNrf2/HO-1 axisoxidative stressPI3K/Akt signalingZebrafish

Identifiers

PMID42352076
PMCPMC13295634

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.